Silvia Velasco
Download PDF
Silvia Velasco
Use the future to build the present
Silvia Velasco
Comment
Stakeholder Type
1.1Advanced AI1.2QuantumRevolution1.3UnconventionalComputing1.4AugmentedReality1.5CollectiveIntelligence2.1CognitiveEnhancement2.2HumanApplicationsof GeneticEngineering2.3HealthspanExtension2.4ConsciousnessAugmentation2.5Organoids2.6FutureTherapeutics3.1Decarbonisation3.2EarthSystemsModelling3.3FutureFoodSystems3.4SpaceResources3.5OceanStewardship3.6SolarRadiationModification3.7InfectiousDiseases4.1Science-basedDiplomacy4.2Advancesin ScienceDiplomacy4.3Foresight,Prediction,and FuturesLiteracy4.4Democracy-affirmingTechnologies5.1ComplexSystemsScience5.2Futureof Education5.3Future Economics,Trade andGlobalisation5.4The Scienceof theOrigins of Life5.5SyntheticBiology
1.1Advanced AI1.2QuantumRevolution1.3UnconventionalComputing1.4AugmentedReality1.5CollectiveIntelligence2.1CognitiveEnhancement2.2HumanApplicationsof GeneticEngineering2.3HealthspanExtension2.4ConsciousnessAugmentation2.5Organoids2.6FutureTherapeutics3.1Decarbonisation3.2EarthSystemsModelling3.3FutureFoodSystems3.4SpaceResources3.5OceanStewardship3.6SolarRadiationModification3.7InfectiousDiseases4.1Science-basedDiplomacy4.2Advancesin ScienceDiplomacy4.3Foresight,Prediction,and FuturesLiteracy4.4Democracy-affirmingTechnologies5.1ComplexSystemsScience5.2Futureof Education5.3Future Economics,Trade andGlobalisation5.4The Scienceof theOrigins of Life5.5SyntheticBiology

Profile:

Silvia Velasco

ProfessorMurdoch Children's Research Institute

    Silvia Velasco leads the Neural Stem Cell Laboratory at the Murdoch Children's Research Institute (MCRI), in Melbourne, Australia. With her team, she is interested in developing pluripotent stem cell-derived 3D organoid models of the human brain to study and advance treatments for neurodevelopmental disorders. Velasco is also a principal investigator at the Novo Nordisk Foundation Center for Stem Cell Medicine (ReNEW), a recently established international collaboration between MCRI, the University of Copenhagen in Denmark, and the University of Leiden in the Netherlands, that strives to advance a new generation of effective and safe stem cell-driven therapies. Prior to establishing her independent Laboratory, Velasco worked in the group of Professor Paola Arlotta at the Broad Institute of MIT and Harvard, USA, where she established a method for the generation of a highly reliable brain organoid model which has been instrumental to gain mechanistic insights into the cell-type specific developmental and functional defects associated with autism spectrum disorder.